(Q33869577)

English

Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Steinhubl SR

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

199-205

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1023/a:1018754309025

0 references

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid platelet-function assay: an automated and quantitative cartridge-based method

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and total platelet glycoprotein IIb/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-Dose Abciximab During Coronary Angioplasty in a Patient with Essential Thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of abciximab induced platelet blockade using a rapid point of care assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1018754309025

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33869577&oldid=1956975767"